Changing Diagnostic Criteria Did Not Expand Cannabis Dependence Uniformly in a Historical Comparison

A historical comparison of DSM-III and DSM-III-R diagnoses found that neither system consistently predominated for cannabis dependence. Changes that expanded diagnoses for some other substances did not necessarily produce the same pattern for cannabis.

The study compared classifications in the same setting

Recent admissions to drug-treatment centers were interviewed with an instrument covering criteria from both systems. Investigators examined agreement, overlap and positive agreement by substance. These measures assess correspondence between classification systems, rather than the biological presence of a drug or impairment at a particular time.

Results differed across substances

The abstract reports a wider dependence classification under DSM-III-R for alcohol, tobacco and amphetamines, but no predominating system for cannabis, opioids or sedative-related categories. A general statement that the revision simply increased every substance diagnosis would therefore be unsupported.

Historical labels cannot be substituted for current criteria

This was a comparison of older diagnostic systems in a treatment-seeking population. It does not establish the prevalence of a current cannabis diagnosis in the general public. Nor can a toxicology result alone determine which interview-based criteria a person met. Drug detection and longitudinal clinical assessment address different evidence.

Interpreting the evidence

When comparing cannabis diagnoses across studies, retain the criteria edition, instrument and population. Apparent changes in diagnostic counts can reflect how a category was defined as well as changes in the people assessed.

Related reading: separate functional and structural endpoints in cannabinoid research.

Research reference

Cottler LB; Helzer JE; Mager D; et al. (1991). Agreement between DSM-III and III-R substance use disorders. Drug and alcohol dependence. doi:10.1016/0376-8716(91)90018-t. Evidence basis: report abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

What Skin Tags Along an Abrasion Can Show About Direction

Knight’s Forensic Pathology explains how superficial skin fragments can help interpret a scraping injury.

Spread the love

Read Article: What Skin Tags Along an Abrasion Can Show About Direction

Why Stomach Contents Provide an Uncertain Timeline After Death

Knight’s Forensic Pathology explains how meal composition and stress complicate estimates based on stomach contents.

Spread the love

Read Article: Why Stomach Contents Provide an Uncertain Timeline After Death

What Did the Confirmatory Phase 3 MDMA-Assisted Therapy Trial Add?

The MAPP2 trial replicated symptom and functional improvements in a more ethnoracially diverse PTSD sample. It also left important questions about blinding, long-term outcomes, exclusions, and sponsor involvement.

Spread the love

Read Article: What Did the Confirmatory Phase 3 MDMA-Assisted Therapy Trial Add?

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us